These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20960191)

  • 41. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2002; (4):CD003189. PubMed ID: 12519588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
    Yamamoto N; Tamura T; Kurata T; Yamamoto N; Sekine I; Kunitoh H; Ohe Y; Saijo N
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):79-88. PubMed ID: 19396598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer.
    Stroh M; Green M; Cha E; Zhang N; Wada R; Jin J
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):485-94. PubMed ID: 26758586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer.
    Stokes ME; Muehlenbein CE; Marciniak MD; Faries DE; Motabar S; Gillespie TW; Lipscomb J; Knopf KB; Buesching DP
    J Manag Care Pharm; 2009 Oct; 15(8):669-82. PubMed ID: 19803556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience.
    Renwick W; Pettengell R; Green M
    BioDrugs; 2009; 23(3):175-86. PubMed ID: 19627169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
    Roh JK; Rha SY; Lee CI; Lee KH; Lee JJ; Shim HJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):312-9. PubMed ID: 9660038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysis.
    Zaïr ZM; Singer DR
    Pharmacogenomics; 2016 Jul; 17(10):1189-1205. PubMed ID: 27380948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient self-testing of white blood cell count and differentiation: A study of feasibility and measurement performance in a population of Danish cancer patients.
    Otto Mattsson T; Lindhart CL; Schöley J; Friis-Hansen L; Herrstedt J
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13189. PubMed ID: 31746087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer.
    La Nasa M; Gaughan J; Cardonick E
    Am J Clin Oncol; 2019 Nov; 42(11):884. PubMed ID: 31644443
    [No Abstract]   [Full Text] [Related]  

  • 52. Incidence of Neonatal Neutropenia, Leukopenia, and Anemia After In Utero Exposure to Chemotherapy For Maternal Cancer.
    Degennaro VA; Tabacco S; Garofalo S; Giannini A; Garufi E; Benedetti Panici P; Lanzone A; De Carolis S
    Am J Clin Oncol; 2019 Oct; 42(10):810-811. PubMed ID: 31569129
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinically-targetable vulnerabilities in cancer metabolism: A systematic review and meta-analysis.
    Javaeed A; Ghauri SK
    J Pak Med Assoc; 2020 Dec; 70(12(A)):2226-2238. PubMed ID: 33475603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Benign ethnic neutropenia; an unrecognised cause of leukopenia in negroid patients].
    van Rooijen CR; Slieker WA; Simsek S
    Ned Tijdschr Geneeskd; 2012; 156(23):A4708. PubMed ID: 22727232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The etiology and management of leukopenia.
    Ing VW
    Can Fam Physician; 1984 Sep; 30():1835-9. PubMed ID: 21279100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of Neonatal Neutropenia, Leukopenia, and Anemia After In Utero Exposure to Chemotherapy For Maternal Cancer: Erratum.
    Am J Clin Oncol; 2019 Dec; 42(12):959. PubMed ID: 31764065
    [No Abstract]   [Full Text] [Related]  

  • 57. LEUKOPENIA, ITS SIGNIFICANCE.
    Catton JH
    Cal State J Med; 1917 Jul; 15(7):264-8. PubMed ID: 18737362
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.
    Aparicio AM; Shen L; Tapia EL; Lu JF; Chen HC; Zhang J; Wu G; Wang X; Troncoso P; Corn P; Thompson TC; Broom B; Baggerly K; Maity SN; Logothetis CJ
    Clin Cancer Res; 2016 Mar; 22(6):1520-30. PubMed ID: 26546618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophils, G-CSF and their contribution to breast cancer metastasis.
    Mouchemore KA; Anderson RL; Hamilton JA
    FEBS J; 2018 Feb; 285(4):665-679. PubMed ID: 28834401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Resistant-Starch-Encapsulated Probiotic Cocktail on Intestines Damaged by 5-Fluorouracil.
    Wang JL; Yeh CH; Huang SH; Wu LS; Chen MC
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.